MVP-mediated exosomal sorting of miR-193a promotes colon cancer progression

Nature Communications

Volumn 8, Issue , 2017, Pages

  Teng, Yun ^a   Ren, Yi ^b   Hu, Xin ^c,d   Mu, Jingyao ^a   Samykutty, Abhilash ^a   Zhuang, Xiaoying ^a   Deng, Zhongbin ^a   Kumar, Anil ^a   Zhang, Lifeng ^a   Merchant, Michael L ^a   Yan, Jun ^a   Miller, Donald M ^a   Zhang, Huang Ge ^a,e  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b THE AFFILIATED HUAIAN NO 1 PEOPLE S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPRIN1; CCND2 PROTEIN; CELL PROTEIN; LUNG RESISTANCE PROTEIN; MICRORNA; MICRORNA 193A; MYC PROTEIN; ONCOPROTEIN; UNCLASSIFIED DRUG; CAPRIN1 PROTEIN, HUMAN; CELL CYCLE PROTEIN; MIRN193 MICRORNA, HUMAN; RIBONUCLEOPROTEIN;

CANCER; CELLS AND CELL COMPONENTS; GENE EXPRESSION; PROTEIN; RNA; TUMOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CANCER GROWTH; CELL COMMUNICATION; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; ENCAPSULATION; EXOSOME; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; LIVER METASTASIS; METASTATIC COLON CANCER; MOUSE; NONHUMAN; PROTEIN RNA BINDING; TUMOR MICROENVIRONMENT; TUMOR SUPPRESSOR GENE; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; BIOLOGICAL MODEL; BLOOD; COLON TUMOR; DISEASE EXACERBATION; GENETICS; LIVER TUMOR; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; RNA TRANSPORT; SECONDARY; TUMOR CELL LINE; TUMOR INVASION;

ANIMALS; BASE SEQUENCE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; COLONIC NEOPLASMS; DISEASE PROGRESSION; EXOSOMES; FEMALE; HUMANS; LIVER NEOPLASMS; MICE, INBRED BALB C; MICRORNAS; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; RNA TRANSPORT; TUMOR MICROENVIRONMENT; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 85013224736     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms14448     Document Type: Article

References (52)

1. Au Yeung, C. L. et al. Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1. Nat. Commun. 7, 11150 (2016).
2. Deng, Z. et al. Enterobacteria-secreted particles induce production of exosomelike S1P-containing particles by intestinal epithelium to drive Th17-mediated tumorigenesis. Nat. Commun. 6, 6956 (2015).
3. Hoshino, A. et al. Tumour exosome integrins determine organotropic metastasis. Nature 527, 329-335 (2015).
4. Zhang, L. et al. Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature 527, 100-104 (2015).
5. Tkach, M. & Thery, C. Communication by extracellular vesicles: where we are and where we need to go. Cell 164, 1226-1232 (2016).
6. Thery, C. Cancer: diagnosis by extracellular vesicles. Nature 523, 161-162 (2015).
7. Bobrie, A. & Thery, C. Exosomes and communication between tumours and the immune system: are all exosomes equal? Biochem. Soc. Trans. 41, 263-267 (2013).
8. Bobrie, A., Colombo, M., Krumeich, S., Raposo, G. & Thery, C. Diverse subpopulations of vesicles secreted by different intracellular mechanisms are present in exosome preparations obtained by differential ultracentrifugation. J. extracell. vesicles 1, 18397 (2012).
9. Thery, C., Ostrowski, M. & Segura, E. Membrane vesicles as conveyors of immune responses. Nat. rev. Immunol. 9, 581-593 (2009).
10. Peinado, H. et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. med. 18, 883-891 (2012).
11. Bobrie, A. et al. Rab27a supports exosome-dependent and-independent mechanisms that modify the tumor microenvironment and can promote tumor progression. Cancer res. 72, 4920-4930 (2012).
12. Trajkovic, K. et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319, 1244-1247 (2008).
13. Lai, C. P., Tannous, B. A. & Breakefield, X. O. Noninvasive in vivo monitoring of extracellular vesicles. Meth. mol. biol. 1098, 249-258 (2014).
14. Zomer, A. et al. Exosomes: fit to deliver small RNA. Commun. integr. biol. 3, 447-450 (2010).
15. Ridder, K. et al. Extracellular vesicle-mediated transfer of functional RNA in the tumor microenvironment. Oncoimmunology 4, e1008371 (2015).
16. Lai, C. P. et al. Dynamic biodistribution of extracellular vesicles in vivo using a multimodal imaging reporter. ACS nano 8, 483-494 (2014).
17. Hannafon, B. N. et al. Plasma exosome microRNAs are indicative of breast cancer. Breast cancer res. 18, 90 (2016).
18. Zoller, M. Exosomes in cancer disease. Meth. mol. biol. 1381, 111-149 (2016).
19. Laurent, L. C. et al. Meeting report: discussions and preliminary findings on extracellular RNA measurement methods from laboratories in the NIH Extracellular RNA Communication Consortium. J. extracell. vesicles 4, 26533 (2015).
20. Hornick, N. I. et al. Serum exosome microRNA as a minimally-invasive early biomarker of AML. Sci. rep. 5, 11295 (2015).
21. Shao, H. et al. Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma. Nat. commun. 6, 6999 (2015).
22. Skog, J. et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. cell biol. 10, 1470-1476 (2008).
23. Teng, Y. et al. Grapefruit-derived nanovectors deliver miR-18a for treatment of liver metastasis of colon cancer by induction of M1 macrophages. Oncotarget 7, 25683-25697 (2016).
24. Thind, A. & Wilson, C. Exosomal miRNAs as cancer biomarkers and therapeutic targets. J. extracell. vesicles 5, 31292 (2016).
25. Munagala, R., Aqil, F. & Gupta, R. C. Exosomal miRNAs as biomarkers of recurrent lung cancer. Tumour biol. 37, 10703-10714 (2016).
26. Shi, R. et al. Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients. Oncotarget 6, 26971-26981 (2015).
27. Chiam, K. et al. Circulating serum exosomal miRNAs as potential biomarkers for esophageal adenocarcinoma. J. gastrointest. surg. 19, 1208-1215 (2015).
28. Warnecke-Eberz, U., Chon, S. H., Holscher, A. H., Drebber, U. & Bollschweiler, E. Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor. Tumour biol. 36, 4643-4653 (2015).
29. Gajos-Michniewicz, A., Duechler, M. & Czyz, M. MiRNA in melanoma-derived exosomes. Cancer lett. 347, 29-37 (2014).
30. Aushev, V. N. et al. Comparisons of microRNA patterns in plasma before and after tumor removal reveal new biomarkers of lung squamous cell carcinoma. PLoS ONE 8, e78649 (2013).
31. Camacho, L., Guerrero, P. & Marchetti, D. MicroRNA and protein profiling of brain metastasis competent cell-derived exosomes. PLoS ONE 8, e73790 (2013).
32. Chugh, P. E. et al. Systemically circulating viral and tumor-derived microRNAs in KSHV-associated malignancies. PLoS pathog. 9, e1003484 (2013).
33. Taylor, D. D. & Gercel-Taylor, C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol. oncol. 110, 13-21 (2008).
34. Costa-Silva, B. et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat. cell biol. 17, 816-826 (2015).
35. Colombo, M., Raposo, G. & Thery, C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Ann. rev. cell dev. biol. 30, 255-289 (2014).
36. Witwer, K. W. et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J. extracell. vesicles 2, 20360 (2013).
37. Thery, C., Amigorena, S., Raposo, G. & Clayton, A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. protoc. cell biol. 30:3.22, 3.22.1-3.22.29 (2006).
38. Zhao, Y. N., He, D. N., Wang, Y. D., Li, J. J. & Ha, M. W. Association of single nucleotide polymorphisms in the MVP gene with platinum resistance and survival in patients with epithelial ovarian cancer. Oncol. lett. 11, 2925-2933 (2016).
39. Balan, S. et al. Major vault protein (MVP) gene polymorphisms and drug resistance in mesial temporal lobe epilepsy with hippocampal sclerosis. Gene 526, 449-453 (2013).
40. Lu, C. & Shervington, A. Chemoresistance in gliomas. Mol. cell. biochem. 312, 71-80 (2008).
41. Yan, X. D., Li, M., Yuan, Y., Mao, N. & Pan, L. Y. Biological comparison of ovarian cancer resistant cell lines to cisplatin and taxol by two different administrations. Oncol. rep. 17, 1163-1169 (2007).
42. Sisodiya, S. M. et al. Vascular colocalization of P-glycoprotein, multidrugresistance associated protein 1, breast cancer resistance protein and major vault protein in human epileptogenic pathologies. Neuropathol. appl. neurobiol. 32, 51-63 (2006).
43. Yi, C. et al. Major vault protein, in concert with constitutively photomorphogenic 1, negatively regulates c-Jun-mediated activator protein 1 transcription in mammalian cells. Cancer res. 65, 5835-5840 (2005).
44. Kolli, S., Zito, C. I., Mossink, M. H., Wiemer, E. A. & Bennett, A. M. The major vault protein is a novel substrate for the tyrosine phosphatase SHP-2 and scaffold protein in epidermal growth factor signaling. J. biol. chem. 279, 29374-29385 (2004).
45. Mossink, M. H., van Zon, A., Scheper, R. J., Sonneveld, P. & Wiemer, E. A. Vaults: a ribonucleoprotein particle involved in drug resistance? Oncogene 22, 7458-7467 (2003).
46. Wu, Y., Zhu, J., Huang, X. & Du, Z. Crystal structure of a dimerization domain of human Caprin-1: insights into the assembly of an evolutionarily conserved ribonucleoprotein complex consisting of Caprin-1, FMRP and G3BP1. Acta Crystallogr. D Struct. Biol. 72, 718-727 (2016).
47. Qiu, Y. Q. et al. Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget. Oncotarget 6, 2148-2163 (2015).
48. Solomon, S. et al. Distinct structural features of caprin-1 mediate its interaction with G3BP-1 and its induction of phosphorylation of eukaryotic translation initiation factor 2alpha, entry to cytoplasmic stress granules, and selective interaction with a subset of mRNAs. Mol. cell. biol. 27, 2324-2342 (2007).
49. Ostrowski, M. et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat. cell biol. 12, 19-30 sup. 1-13 (2010).
50. Pu, Y. et al. MiR-193a-3p and miR-193a-5p suppress the metastasis of human osteosarcoma cells by down-regulating Rab27B and SRR, respectively. Clin. exp. metastasis 33, 359-372 (2016).
51. Xiang, X. et al. miR-155 promotes macroscopic tumor formation yet inhibits tumor dissemination from mammary fat pads to the lung by preventing EMT. Oncogene 30, 3440-3453 (2011).
52. Liu, Y. et al. COP9-associated CSN5 regulates exosomal protein deubiquitination and sorting. Am. j. pathol. 174, 1415-1425 (2009).